Meta-analysis:influence of Utillin “s” on human CD8+T cells

Abstract

Abstract: AIM: To study the influence of Utilin“s” on human CD₈⁺ T cells. METHODS: Papers about the subject were searched from electronic documental databases.RevMan4.2 software was used for Meta-analysis during the procedure of evaluating, and SASv9.0 software was used to draw the funnel plot. RESULTS: Eight papers were found, and there was no statistical difference in CD₈⁺T cells between before and after using Utilin “ s”(P =0.12). CONCLUSION: No evidence suggests that the Utilin “ s” has significant influence on human CD₈⁺T cells.

Key words: Utillin"s", Meta-analysis, modulationof immune function, CD₈⁺T Cells

CLC Number:

R446.63

XU Yong-qiang, RUI Jing, LIU Chang-bao, CHEN Rong. Meta-analysis:influence of Utillin “s” on human CD₈⁺T cells[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(1): 62-65.

References

[1] 陈素玲, 王明保, 赵美蓉, 等. 化疗并用乌体林斯治疗耐药肺结核疗效观察[J]. 实用预防医学, 2000;7: 421-423.
[2] 李强, 任敏, 朱江, 等. 乌体林斯注射液在治疗晚期肺癌中疗效的初步观察[J]. 四川肿瘤防治, 2002;15: 229-230.
[3] 李忆, 徐树英, 张玲. 乌体林斯对结核病的治疗效果分析[J]. 中国综合临床, 2003;19: 427-429.
[4] 廖志勤, 和强, 封稚, 等. 乌体林斯注射液治疗小儿支气管哮喘的疗效及其对免疫指标的影响[J]. 广东医学院学报, 2003;21: 547-549.
[5] 彭丽萍, 许力军, 吕小红. 乌体林斯对结核性胸膜炎患者IgG、IgA、IgM 、CD₃⁺ 、CD₄⁺ 、CD₈⁺ 、NK 及胸水吸收的影响[J]. 吉林大学学报(医学版), 2004;30: 922-924.
[6] 申郑堂, 海健, 毛杰. 乌体林斯注射液对乳腺癌患者辅助化疗后免疫功能的影响[J]. 中国医师杂志, 2003;5: 122-123.
[7] 粟振德. 乌体林斯联合阿昔洛韦治疗复发性生殖器疱疹的临床疗效及其免疫调节作用[J]. 实用预防医学, 2005;12: 311-312.
[8] 张国祥, 严秀娟. 乌体林斯注射液治疗老年慢性肺心病的临床研究[J]. 中国现代应用药学杂志, 2001;18: 327-329.
[9] 懂碧蓉, 欧雪梅, 赵伟业. 发表性偏倚对系统评价的影响[J]. 中国循证医学, 2001;3: 170-173.
[10] 欧爱华, 老膺荣, 李晓庆, 等. 多中心临床随机对照试验的Meta 分析[J]. 中华流行病学杂志, 2005;26: 290-293.
[11] Roitt IM, Delves PJ. Roitt' s essential immunology[M]. 第10版. 北京: 高等教育出版社, 2002: 204-205.
[12] 刘红霞, 郑青山. 左氧氟沙星与其他抗生素治疗下呼吸道感染的有效性和安全性对照研究的Meta 分析[J]. 中国临床药理学与治疗学, 2005;10: 795-798.
[13] Manheimer E, White A, Berman B, et al. Meta-analy sis: acupuncture for low back pain[J]. Ann Intern Med, 2005;142: 651-663.
[14] Shafiq N, Malhotra S, Pandhi P, et al. A meta-analysis of clinical trials of paclitaxel-and sirolimus-eluting stents in patients with obstructive coronary artery disease[J]. Br J Clin Pharmacol, 2005;59: 94-101.
[15] Hartling/L, Wiebe N, Russell K, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis[J]. Arch Pediatr Adolesc Med, 2003;157: 957-964.
[16] 孙振球, 主编. 医学综合评价方法及其应用[M]. 北京: 化学工业出版社, 2006: 182-196.

Meta-analysis:influence of Utillin “s” on human CD₈⁺T cells

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	MA Guangli, ZHANG Jing. Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
[2]	YE Hongbo, SONG Yangyang, XUE Ling, RUI Jianzhong. Meropenem population pharmacokinetic model for the Chinese elderly established by model-based META analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 984-990.
[3]	YU Zhaolei, BAI Jianling, YU Hao, ZHAO Yang. Development of tools for clinical trial information retrieval and Meta-analysis based on R-Shiny: Taking non-small cell lung cancer as an example [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 984-991.
[4]	CHEN Wenjun, RUAN Zourong, XIANG Xiaoqiang. Development and application progress of physiologically based pharmacokinetic modeling and its combined use with other modeling methods [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 299-305.
[5]	LI Lujin, DING Junjie, LIU Dongyang, WANG Xipei, DENG Chenhui, JI Shangmin, CHEN Wenjun, MA Guangli, WANG Kun, SHENG Yucheng, XU Ling, PEI Qi, CHEN Yuancheng, CHEN Rui, SHI Jun, LI Gailing, WANG Yaning, WANG Yuzhu, XIE Haitang, ZHOU Tianyan, FANG Yi, ZHANG Jing, JIAO Zheng, HU Bei, ZHENG Qingshan. General considerations of model-based meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1250-1267.
[6]	SHAO Yaojun, ZHENG Tong,WANG Yanqiu,LIU Ling,YAO Yingshui. Nimodipine combined with flunarizine for preventing and treating migraine: A Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 646-652.
[7]	WANG Weiyu, YU Hao. Effects of gray drugs in patients with coronary heart disease: A network Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 301-307.
[8]	WU Jiaqi, YANG Qiaowen, CHEN Xiumin, HUANG Runyue, HUANG Qingchun, ZHAO Yue, WU Xiaodong. Efficacy and safety of iguratimod combined with methotrexate in rheumatoid arthritis: A systematic review and Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1132-1140.
[9]	ZHANG Xiaoyu, FANG Zhengmei, YAO Yingshui. Association of leptin and leptin receptor gene polymorphisms with hypertension: a Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 910-916.
[10]	LI Yun, LI Bingsheng, ZHANG Weifang, LI Yixiu, LI Chun, PENG Juan, LAI Xin, ZHU Jing, XU Ruilai, XIONG Aizhen. Association study of miR-146a G>C polymorphisms with susceptibility of hepatocellular carcinoma in the Chinese population: a Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 779-786.
[11]	RONG Guoyi, WANG Shumei, TANG Mo. Efficacy of reducing phlegm with traditional Chinese medicine on non-small cell lung cancer: a Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 787-794.
[12]	WU Changjuan, TANG Tiansheng. Efficacy of Zhenyuan capsule as adjuvant therapy for chronic heart failure: a Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 299-304.
[13]	CHEN Jiaren, CUI Yudi, TIAN Hao, WANG Hao. Vortioxetine for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 52-59.
[14]	HANG Yongfu, LU Guoyuan, SHEN Lei, GAO Jie, QIAO Qing, LI Ming, SHA Wengang, ZHOU Ling, DING Xiaoliang, XIE Cheng. Efficacy and safety of leflunomide for IgA nephropathy：A meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 60-67.
[15]	HU Jing, ZHU Jun-rong, YU Feng. Efficacy and safety of warfarin dosage algorithms in clinical application:A Meta-analysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(3): 296-303.